Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $131.40 USD
Change Today +0.75 / 0.57%
Volume 60.5K
TFX On Other Exchanges
New York
As of 5:15 PM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

550 East Swedesford Road

Suite 400

Wayne, PA 19087

United States



Teleflex Incorporated provides medical technology products. The company primarily designs, develops, manufactures, and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of its direct sales force and distributors. It also offers its products to original equipment manufacturers of medical devices through its own sales forces through independent representatives and through independent distributor networks. Segments The company conducts its operations through six segments, including Vascular North America, Anesthesia/Respiratory North America, Surgical North America, EMEA (Europe, the Middle East and Africa), Asia, and OEM. Vascular North America This segment’s vascular access products facilitate various critical care therapies, including the administration of intravenous medications and other therapies and the measurement of blood pressure and taking of blood samples through a single puncture site. Its vascular access devices, are primarily catheters and related devices. ARROW central venous catheters (CVCs): The ARROW CVCs are inserted in the neck or shoulder area and come in multiple lengths and up to four channels, or lumens. The ARROW CVC has a pressure injectable option, which gives clinicians who perform contrast-enhanced CT scans the ability to use an indwelling (in the body) pressure injectable ARROW CVC to inject contrast dye for the scan without having to insert a second catheter. Arrow EZ-IO system: EZ IO, which was added to the company’s vascular product portfolio through its acquisition of Vidacare Corporation (Vidacare) in 2013, provides immediate vascular access for the delivery of medications and fluids through the intraosseous, or in the bone, route when traditional vascular access is difficult or impossible. In emergency situations, EZ IO enables access to deliver lifesaving therapies to help stabilize a patient until a traditional catheter can be inserted. ARROW Jugular Axillo-Subclavian Central Catheters (JACCs), with Chlorag+ard technology: JACCs are inserted in the neck or shoulder area and provide an alternative to traditional acute CVCs and peripheral central venous access. In 2013, this CVC for acute or long-term use combines antimicrobial and antithrombogenic protection with smaller external diameter sizes. This product suited for patients with renal issues, chronic patients with poor peripheral access or those with a history of or risk for venous thrombosis. ARROW Peripherally Inserted Central Catheters (PICCs): The ARROW PICCs are soft, flexible catheters that are inserted in the upper arm and into a vein that carries blood to the heart to administer various types of intravenous medications and therapies. ARROW PICCs have a pressure injectable option that can withstand the higher pressures required by the injection of contrast media for CT scans. ARROW VPS: The ARROW VPS is a vascular positioning system that facilitates precise placement of a PICC or CVC within the heart. The ARROW VPS analyzes multiple metrics, in real time, from its biosensor to help clinicians navigate through the circulatory system and precisely identify the correct catheter tip placement in the heart. Cleared by the United States Food and Drug Administration (FDA) as an alternative to chest X-ray confirmation, the ARROW VPS can help to shorten hospital stays while lowering costs associated with catheter insertion procedures. In 2013, the company launched the next generation of its ARROW VPS, the ARROW VPS G4, which provides further enhancements to its VPS technology, such as the ability to provide information as to the final catheter position, improved sterile field capability and integration with hospital data management systems. ARROW Arterial Catheterization Sets: These sets facilitate arterial pressure monitoring and blood withdrawal for glucose, blood-gas and electrolyte measurement in a wide variety of critical care and intensive care settings. ARROW Per


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TFX:US $131.40 USD +0.75

TFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
IDEXX Laboratories Inc $70.67 USD +0.43
PerkinElmer Inc $53.58 USD +0.42
Cooper Cos Inc/The $146.96 USD +1.65
West Pharmaceutical Services Inc $64.13 USD +0.51
View Industry Companies

Industry Analysis


Industry Average

Valuation TFX Industry Range
Price/Earnings 31.6x
Price/Sales 3.0x
Price/Book 2.8x
Price/Cash Flow 28.0x
TEV/Sales 2.3x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TELEFLEX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at